Biogen CLO Michael Parini Receives 7,405 Restricted Stock Units
BIOGEN INC.
Subscribe to track BIIB
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Biogen Inc. ($BIIB) Form 4 Filing Update Insider: Michael Parini (Chief Legal Officer) Transaction: Grant of 7,405 Restricted Stock Units (RSUs) at $0.00 Transaction Date: September 1, 2026 Post-Transaction Holdings: 7,405 RSUs Significance: Low (Routine annual/retention equity grant vesting over 3 years)
Comprehensive Analysis
Biogen Inc. ($BIIB) Form 4 Transaction Analysis
Executive Summary On September 3, 2026, Biogen Inc. filed a Form 4 disclosing that Michael Parini, Chief Legal Officer, was awarded 7,405 Restricted Stock Units (RSUs) on September 1, 2026.
Transaction Overview
- Insider: Michael Parini
- Role: Chief Legal Officer
- Security: Restricted Stock Units
- Transaction Code:
A(Grant/Award) - Units Granted: 7,405
- Exercise/Purchase Price: $0.00
- Post-Transaction Derivative Holdings: 7,405 RSUs
- Vesting Terms: RSUs vest in three equal annual installments starting on September 1, 2027.
Market & Trading Significance This filing represents a standard equity compensation grant rather than an open-market transaction. Routine RSU grants align executive compensation with shareholder value and do not indicate direct discretionary buying or selling activity. Trading significance is assessed as Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.